Evidence map›Paper›PMID 40705276›Full record

ReviewPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2025

Advancements and emerging trends in photodynamic therapy: innovations in cancer treatment and beyond.

Mohamed Z El-Sadek, Mostafa K Abd El-Aziz, Ahmed H Shaaban, Salah Abdelfatah Mostafa, Al-Hassan Soliman Wadan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Redox processes in the treatment of advanced skin cancers.Clinical & experimental metastasis · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. An integrated microfluidic culture model for photodynamic therapy evaluations under normoxic and hypoxic conditions.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed Z El-SadekDepartment of Biology, Faculty of Science, Galala University (15888), Galala Plateau, Attaka, Suez, Egypt.
Mostafa K Abd El-AzizFaculty of Pharmacy, King Salman International University, Ras-Sudr, South Sinai, Egypt.
Ahmed H ShaabanDepartment of Biology, Faculty of Science, Galala University (15888), Galala Plateau, Attaka, Suez, Egypt.
Salah Abdelfatah MostafaBiotechnology Program, Faculty of Agriculture, Ain Shams University, Ain Shams, Egypt.
Al-Hassan Soliman WadanDepartment of Oral Biology, Faculty of Dentistry, Galala University, Galala Plateau, Attaka, Suez, 15888, Egypt. Alhassan.soliman.168@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) has emerged as a sophisticated, non-invasive therapeutic approach for treating various malignancies and non-oncological conditions. This review examines the fundamental principles and recent advances in PDT oncological applications. PDT's mechanism relies on the selective accumulation of photosensitizers (Ps) in pathological tissues followed by localized activation via specific wavelengths of light, generating cytotoxic species that induce tumor cell death while sparing adjacent healthy tissues. Despite its proven efficacy, conventional PDT faces limitations, including suboptimal Ps delivery, insufficient tissue penetration, and potential side effects. Recent breakthroughs in nanotechnology have created unprecedented opportunities to overcome these challenges through engineered nanocarriers that improve photosensitizer pharmacokinetics, biodistribution, and target specificity. This review explores multifunctional nanoformulations combining PDT with complementary therapeutic modalities such as photothermal therapy and chemotherapy. The review also addresses emerging trends in clinical translation, highlighting recent trials that demonstrate promising outcomes across multiple cancer types. We conclude by identifying remaining challenges and future directions for optimizing enhanced PDT as a precision anticancer strategy with the potential to impact standard treatment protocols for various malignancies significantly.

Indexed as

NeoplasmsPhotochemotherapyPhotosensitizing AgentsAnimalsHumansNanoparticlesPhotosensitizing AgentsCancer treatmentMultimodal therapyPhotodynamic therapyPhotosensitizersTargeted drug delivery

Identifiers

PMID40705276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.